A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells  by Polo, Jose M. et al.
ResourceAMolecular Roadmap of Reprogramming
Somatic Cells into iPS Cells
Jose M. Polo,1,2,3,4,11 Endre Anderssen,1,2,5,11 Ryan M. Walsh,1,2 Benjamin A. Schwarz,1,2 Christian M. Nefzger,3
Sue Mei Lim,3 Marti Borkent,1,2,6 Effie Apostolou,1,2 Sara Alaei,3 Jennifer Cloutier,1,2 Ori Bar-Nur,1,2 Sihem Cheloufi,1,2
Matthias Stadtfeld,1,2,12 Maria Eugenia Figueroa,7,13 Daisy Robinton,1,2 Sridaran Natesan,8 Ari Melnick,7 Jinfang Zhu,9
Sridhar Ramaswamy,1,2,5,* and Konrad Hochedlinger1,2,10,*
1Massachusetts General Hospital Cancer Center and Center for Regenerative Medicine, 185 Cambridge Street, Boston, MA 02114, USA
2Harvard Stem Cell Institute, 1350 Massachusetts Avenue, Cambridge, MA 02138, USA
3Monash Immunology and Stem Cell Laboratories
4Adjunct to Australian Regenerative Medicine Institute
Monash University, Wellington Rd, Clayton, Vic 3800, Australia
5Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA 02142, USA
6Erasmus Medical Center Rotterdam, Department of Reproduction and Development, Dr. Molewaterplein 50, 3015 GE Rotterdam,
the Netherlands
7Department of Medicine, Hematology Oncology Division, Weill Cornell Medical College, New York, NY 10065, USA
8Sanofi-Aventis, 270 Albany Street, Cambridge, MA 02139, USA
9National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA
10Howard HughesMedical Institute and Department of StemCell and Regenerative Biology, Harvard University and HarvardMedical School,
7 Divinity Avenue, Cambridge, MA 02138, USA
11These authors contributed equally to this work
12Present address: New York University School of Medicine, 540 First Ave, New York, NY 10016, USA
13Present address: University of Michigan Medical School, 1301 Catherine Road, Ann Arbor, MI 48109, USA
*Correspondence: sridhar@mgh.harvard.edu (S.R.), khochedlinger@helix.mgh.harvard.edu (K.H.)
http://dx.doi.org/10.1016/j.cell.2012.11.039SUMMARY
Factor-induced reprogramming of somatic cells into
induced pluripotent stem cells (iPSCs) is inefficient,
complicating mechanistic studies. Here, we exam-
ined defined intermediate cell populations poised to
becoming iPSCs by genome-wide analyses. We
show that induced pluripotency elicits two transcrip-
tional waves, which are driven by c-Myc/Klf4 (first
wave) and Oct4/Sox2/Klf4 (second wave). Cells that
become refractory to reprogramming activate the
first but fail to initiate the second transcriptional
wave and can be rescued by elevated expression of
all four factors. The establishment of bivalent do-
mains occurs gradually after the first wave, whereas
changes in DNA methylation take place after the
second wave when cells acquire stable pluripotency.
This integrative analysis allowed us to identify genes
that act as roadblocks during reprogramming and
surface markers that further enrich for cells prone to
forming iPSCs. Collectively, our data offer newmech-
anistic insights into the nature and sequence of
molecular events inherent to cellular reprogramming.
INTRODUCTION
Induced pluripotent stem cells (iPSCs) have been generated
from a number of mouse and human cell types upon enforcedCexpression of transcription factors such as Oct4, Klf4, Sox2,
and c-Myc (OKSM) (Takahashi et al., 2007; Takahashi and
Yamanaka, 2006). iPSCs provide a valuable source of patient-
specific cells for the study and potential treatment of human
diseases (Wu and Hochedlinger, 2011). In addition, iPSC tech-
nology offers a unique tool to dissect the principles of cell fate
determination during normal development and its dysregulation
in disease (Stadtfeld and Hochedlinger, 2010).
In general, less than 3% of somatic cells expressing OKSM
give rise to iPSC colonies, complicating efforts to dissect the
mechanisms of reprogramming. Owing to this limitation, most
previous studies focused on the immediate response of somatic
cells to factor expression. For example, fibroblasts were shown
to go through a process that was reminiscent of amesenchymal-
to-epithelial transition (MET) within a few days of OKSM expres-
sion (Li et al., 2010; Samavarchi-Tehrani et al., 2010). At the
epigenetic level, widespread remodeling of certain histonemodi-
fications, but not of DNA methylation patterns, was seen within
the first few cell divisions of iPSC induction (Koche et al.,
2011). However, intermediate and late stages of reprogramm-
ing have remained inaccessible for more detailed molecular
analyses.
We and others have documented that fibroblasts undergoing
reprogramming pass through a number of defined intermediates
(Brambrink et al., 2008; Stadtfeld et al., 2008). Briefly, cells ex-
pressing OKSM from doxycycline (dox)-inducible lentiviral
vectors initially downregulate the fibroblast-associated marker
Thy1 (day 1–2), then activate the SSEA1 antigen (day 3–5) and
eventually upregulate an Oct4-GFP reporter (day 8–10) before
forming stable iPSC colonies at approximately 1.5 weeks.ell 151, 1617–1632, December 21, 2012 ª2012 Elsevier Inc. 1617
Importantly, isolation of these rare cell populations with the
aforementioned markers allowed us to significantly enrich for
cells that are poised to becoming iPSCs. Here, we have utilized
this approach, in combination with a transgenic system that
enables homogeneous dox-inducible OKSM expression in
somatic cells (Stadtfeld et al., 2010), to purify intermediate
stages of iPSC formation with the goal to elucidate the
nature and sequence of molecular changes specific to cellular
reprogramming.
RESULTS
Experimental Approach to Studying Rare
Reprogramming Intermediates
We first determined whether the reprogramming of fibroblasts
with a recently reported dox-inducible transgenic system
(‘‘reprogrammable system’’) (Stadtfeld et al., 2010) generates
the same subpopulations of cells that we have previously
described by using direct lentiviral infection (Stadtfeld et al.,
2008). As shown in Figure 1A, murine embryonic fibroblasts
(MEFs) carrying the Col1a1-tetO-OKSM transgene, the
ROSA26-M2-rtTA allele, and an Oct4-GFP knockin reporter
gave rise to Thy1 cells, SSEA1+ cells, and Oct4-GFP+ cells
with the expected kinetics. To verify that these intermediate pop-
ulations were indeed enriched for cells that would form iPSCs,
we sorted cells on feeders based on Thy1, SSEA1, and GFP
expression and treated them with dox for an equal number of
days (see Extended Experimental Procedures). Consistent with
our previous report, intermediate cells with the potential to give
rise to iPSCs were initially present within both the Thy1 and
SSEA1+ populations, then progressed to SSEA1+ cells, and
ultimately transited to the SSEA1+, Oct4-GFP+ population
(Figures 1B and 1C). Importantly, sorting of Thy1+ cells after
day 3 and of Thy1 cells after day 6 consistently failed to yield
iPSC colonies, indicating that these cell populations had
become refractory to reprogramming.
To examine the phenotypic progression of reprogramming
intermediates, we sorted Thy1+, SSEA1+, and Oct4-GFP+ cells
after 3, 6, 9, and 12 days of dox induction, followed by culture in
dox for another 3 days before reassessing their surface pheno-
type (Figure 1C). This analysis, combined with the abovemen-
tioned reprogramming results (Figure 1B), documents that (1)
cells undergoing successful reprogramming with the Col1a1-
tetO-OKSM transgenic system transit in a linear fashion from
a Thy1+ to a Thy1 to a SSEA1+ state in the first 6 days and
eventually to a SSEA1+, Oct4-GFP+ state by days 9–12 (see Fig-
ure 1D for graphic summary; red arrows connect intermediates
progressing toward iPSCs); (2) SSEA1+ cells are phenotypically
still plastic until days 9–12 when they undergo commitment to
a stable pluripotent cell fate; and (3) Thy1+ cells lose their ability
to progress toward a Thy1 and SSEA1+ state as early as day 3.
Note that progressing intermediates account for only 5%–10%
of cells in regular reprogramming cultures compared with
90%–95% of Thy1+/Thy1 cells.
We generated gene expression profiles for these intermediate
cell populations as well as for noninduced Thy1+ MEFs (day 0)
and dox-independent iPSCs (see Table S1, available online,
for searchable database). Examination of candidate genes1618 Cell 151, 1617–1632, December 21, 2012 ª2012 Elsevier Inc.confirmed that Thy1 was downregulated and SSEA1 (synthe-
sized by the gene product of Fut9 [Kudo et al., 2004]) was
upregulated in the Thy1 and SSEA1+ populations, respectively
(Figure 1E; note that red line depicts progressive intermediates
as defined in Figure 1D by red solid arrows, whereas black line
shows refractory Thy1+ cells). In addition, we noticed that
Snai1 became downregulated, whereas E-Cadherin was upre-
gulated at day 3, consistent with the occurrence of a MET.
Alkaline phosphatase (Alpl) and Fbxo15, early markers of plurip-
otent cells, gradually increased their expression, whereas
endogenous Oct4 and Sox2 transcripts were detectable only
late during iPSC generation. Lastly, Cyclin B1 became upregu-
lated and the CDK inhibitor Cdkn2b (encoding for p15) was
downregulated early in reprogramming. It is worth mentioning
that Thy1+ cells mirrored the gene expression changes of pro-
gressing cells until day 3 but then failed to sustain this trend at
later time points, which correlated with their inability to produce
iPSCs after day 3 (Figure 1B). We conclude that our sorting
strategy allows us to analyze gene expression patterns of
progressive intermediate cell populations transitioning toward
iPSCs (Figure 1C) and to distinguish these from patterns in the
bulk population of cells that are refractory to reprogramming.
Major Gene Expression Changes Occur in Two
Discernible Phases during iPSC Formation
Principle component analysis (PCA) of the cell populations re-
vealed a molecular connectivity reflecting their progression
from the initial Thy1+ cells toward Thy1 cells and ultimately
SSEA1+ cells, Oct4-GFP+ cells and iPSCs as depicted by the
dashed red line (Figure 2A). PCA analysis further showed that
all intermediates at day 3 clustered together, indicating that cells
responded homogeneously to OKSM activation within the first
few days. After day 3, however, SSEA1+ cells progressed
toward Oct4-GFP cells, which were most closely related to
established iPSCs, demonstrating that the SSEA1+ population
gradually evolved toward a bona fide pluripotent state with
time. Unsupervised clustering confirmed the similarities of
SSEA1+ cells at days 3–9 and of Oct4-GFP+ cells at day 12
and iPSCs (Figure 2B). An examination of the number of differen-
tially expressed genes between progressing (SSEA1+) and
refractory (Thy1+) cell populations at each time point showed
a gradual increase, which culminated at 1,500 genes by day
12 (Figure 2C). These observations document that the isolation
of subpopulations with experimentally proven distinct reprog-
ramming potentials are distinguishable by global gene expres-
sion patterns.
Remarkably, a comparison of relative gene expression
changes among pairs of progressing cell populations at succes-
sive time points revealed two distinct waves of major gene
activity (Figure 2D, left). The first wave occurred between days
0 and 3, whereas a second wave was detectable toward the
end of reprogramming, after day 9. Refractory Thy1+ cells initi-
ated the first wave but failed to undergo the second wave
(Figure 2D, right). Gene ontology (GO) analysis showed that
expression changes within the first phase involved activation of
processes related to cell proliferation, metabolism, cytoskeleton
organization, and downregulation of genes associated with
development. Genes upregulated during the second phase
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Figure 1. Strategy for Isolating Reprogramming Intermediates
(A) FACS analysis of reprogrammable MEFs at indicated time points. 12+4 denotes transgene-independent growth for 4 days.
(B) Comparison of reprogramming efficiencies of intermediates purified at indicated time points. Note that established iPSCs have a colony formation efficiency of
30% (Stadtfeld et al., 2008). Data are represented as mean ± SEM (n = 3).
(C) Pie charts summarizing FACS analysis of reprogrammable cells at indicated time points (top row). Bottom row shows FACS analysis for Thy1, SSEA1 and
Oct4-GFP 3 days after sorting and plating of the above cell populations in the presence of doxycycline.
(D) Scheme illustrating the different subpopulations throughout reprogramming. Solid red arrows connect cell populations progressing toward iPSCs as inferred
from data in (B).
(E) Expression analyses of indicated genes at day 0, 3, 6, 9, and 12 of reprogramming and in established iPSCs (black lines depict Thy1+ populations; red lines
depict cells undergoing successful reprogramming as defined by red arrows in Figure 1D).
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Figure 2. Gene Expression Dynamics during iPSC Formation
(A) Principal component analyses of global gene expression data of FACS-sorted subpopulations at indicated time points.
(B) Unsupervised hierarchical clustering of gene expression profiles of indicated cell populations.
(C) Number of differentially expressed genes between Thy1+ and SSEA1+ cells at indicated time points.
(D) Number of differentially expressed (DE) genes in progressing SSEA1+ cells at successive time points. Right panel shows gene expression changes in
refractory Thy1+ cells.
(legend continued on next page)
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were associated with embryonic development and stem cell
maintenance. A parallel study, which applied proteomics to
study the same intermediates of reprogramming, concurs with
our findings and further shows that molecular changes are highly
coordinated during both phases (Hansson et al., 2012).
Together, these data demonstrate that cells undergoing reprog-
ramming into iPSCs, as defined by populations upregulating
SSEA1+ at early time points and SSEA1+/Oct4-GFP at late
time points, undergo a biphasic process at the transcriptional
level that is separated by a period of less pronounced transcrip-
tional change.
Defining Reprogramming-Specific Gene Expression
Patterns
To gain further insights into the mechanisms of iPSC induction,
we next determined categories of genes that changed their
expression in characteristic patterns (Figure 2E and Table S1).
A large number of genes became abruptly upregulated (cluster
I;750 genes) or downregulated (cluster VI;1,200 genes) early
in reprogramming and then remained largely unchanged until the
iPSC state. Genes in these two categories were mainly involved
in controlling DNA replication and cell division processes (upre-
gulated genes) as well as cell adhesion and cell-cell contacts
(downregulated genes) and account for the first transcriptional
wave during reprogramming. Another category was comprised
of400 genes that were gradually upregulated, such as the plu-
ripotency-associated genes Alpl, Fbx15, Nr0b1, Tcfcp2l1, and
Sall1 (cluster II), whereas roughly 350 genes were induced late
during reprogramming and contained genes enriched for the
categories stem cells and DNA binding (cluster III). The latter
group, which contained well-known core pluripotency factors
such as Nanog, Oct4, and Sox2 as well as Esrrb, Dnmt3L, Tcl1,
and Nr5a2, is in part responsible for the second transcriptional
wave and marks the acquisition of a stable pluripotent state.
Intriguingly, we also identified categories of genes that were
either transiently up- or downregulated during iPSC formation
(cluster IV and VIII, respectively) or upregulated early and down-
regulated late (cluster V). Geneswithin those categories included
a number of developmental and cell-type-specific regulators
such as Bcl11a, Prx, and Tbx21 among the transiently upregu-
lated genes and Spp1, Pitx2, and Six4 among the transiently
downregulated genes (Figure 2E).
Lastly, we hypothesized that the manipulation of dynamically
regulated genes from these categories might enhance reprog-
ramming. We selected the Akt coactivator Tcl1, the transcription
factors Tcfap2c and Hesx1 and the ESC-specific Ras isoform
ERas for overexpression experiments and the fibroblast-
enriched genes Meox1 and Meox2 for knockdown experiments
(Figure 2F). Accordingly, upregulation or downregulation of
theses genes gave rise to up to seven times more Oct4-GFP+(E) Gene expression categories (I to IX) clustered by common expression chang
Thy1+ population; red trendlines depict gene expression patterns in cells under
represented once per category.
(F) Expression analysis of candidate genes selected from (E) for overexpression or
in brackets.
(G) Reprogramming potential of OKSM transgenic MEFs infected with lentiviral v
Data are represented as mean ± SEM (n = 3). See also Figure S1.
Ccolonies compared with control cells (Figure 2G). Collectively,
these experiments prove that our gene expression categories
facilitate the identification of molecules that positively or nega-
tively influence the reprogramming process.
Gene Expression Patterns of Refractory Cells
Another category of genes (cluster IX) contained about 200genes
that were aberrantly activated in refractory Thy1+ cells (Figure 2E
and Table S1). Genes within this class were related to extracel-
lular space/matrix, plasma membrane, retinoic acid binding,
and immune response processes (e.g., Mmp13, Rarres2,
Fgf18, Fndc1, Aqp1 and 4, Il1f10, Hsd11b1, and Figure S1A)
and likely contributed to the failure of Thy1+ cells to reprogram.
To further understand the molecular reasons for the inability of
Thy1+ intermediates to reprogram, we analyzed other genes that
were differentially expressed between SSEA1+ and Thy1+ cells.
This analysis revealed that mesenchymal genes were not
properly downregulated, whereas epithelial genes failed to be
upregulated in Thy1+ cells compared to SSEA1+ cells after
day 3 (Figure S1B). We also searched for differentially expressed
genes between Thy1+ and SSEA1+ cells at day 3, when overall
gene expression patterns were still highly similar among all
populations (Figure 2A). This analysis yielded a small number
of significantly up and downregulated genes (e.g., Il6, Nup210,
and Bex1) that might serve as valuable early discriminators
between cells that succeedor fail in reprogramming (Figure S1C).
We conclude that Thy1+ cells become refractory to reprogram-
ming for a variety of reasons that include (1) an inability to
undergo a MET, (2) aberrant activation of differentiation and
immune-response-associated genes, and (3) a failure to main-
tain global gene expression trends beyond day 3.
Impact of Cellular Heterogeneity on Molecular
Dissection of Reprogramming
We employed different strategies to determine the degree of
heterogeneity among SSEA1+ cells. First, we used Fluidigm
technology to perform single-cell expression analysis for 26
genes (see Figure S2A) in FACS-purified SSEA1+ intermediates
at days 3, 6, and9aswell as in day 0Thy1+MEFsandestablished
iPSCs.Correspondence analysis (COA) of all 26 genes across the
different cellular groups showed that the three intermediate
populations formed separate clusters that partially overlapped
and gradually progressed from MEFs to iPSCs (Figure 3A).
COA confirmed the early and late transcriptional waves and
illustrated an increased degree of variation within SSEA1+ inter-
mediates compared with MEFs and iPSCs (Figure 3B). Biplot
analysis suggested that activation of Nr5a2, ERas, Zfp42, Esrrb,
Dnmt3l, and PECAM was most informative for predicting the
iPSC state, followed by activation of Nanog, Lin28, and EpCAM
(Figure 3C). A comparison of the expression dynamics ofes during reprogramming (black trendlines depict gene expression patterns in
going successful reprogramming as defined in Figure 1D). Each gene is only
knockdown experiments shown in (G). Gene expression categories are shown
ectors expressing the indicated candidate genes or hairpins.
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(A) Correspondence analysis (COA) of single-cell expression data obtained with Fluidigm technology for 26 genes in indicated cell populations.
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individual genes between SSEA1+ bulk populations and single
SSEA1+ cells revealed a similar overall kinetics and allowed us
to differentiate between MEF- and ESC-associated genes that
were either downregulated or upregulated immediately, gradu-
ally or late upon reprogramming factor expression (Figure 3D).
We next examined the shape of the violin plots (Figure 3D) in
order to deduce whether gene expression changes took place
in aminority ormajority of SSEA1+ intermediates; whereas unim-
odal plots are consistent with uniform gene expression in
amajority of cells, bimodal plots are indicative of distinct expres-
sion patterns and thus heterogeneous cell populations. We
could distinguish between three characteristic patterns of gene
expression change (Figure 3D and Figure S2B): (1) exclusively
unimodal expression patterns, which were mostly characterized
by genes that changed in one of the two transcriptional waves
and included MEF genes that were silenced early (Fibin, Snai1)
or gradually (Fbn1) as well as all examined pluripotency genes
that were activated late (Zfp42, Esrrb, Nr5a2, ERas, Lin28,
PECAM, Tcl1, Dnmt3l); (2) unimodal expression early and late
with bimodal expression at intermediate stages of reprogram-
ming, which contained the MEF gene Zfpm and the early iPSC
marker EpCAM, Nanog and Tcfap2c; and (3) bimodal expression
patterns at all time points. Examples included the MEF gene
Hoxa10 and the intermediate-specific genes Cldn11, Tbx21,
and Six4. Coexpression analysis of representative genes from
each category showed that they were indeed activated within
the same cells (Figure S2C).
To determine whether intermediate-specific genes were
always expressed heterogeneously within SSEA1+ cells (Fig-
ure 3D), we performed immunohistochemistry (IHC) for Prx (Fig-
ure 3E) in reprogrammable MEFs induced with dox for 9 days.
Costaining with antibodies recognizing SSEA1 and Prx revealed
that all SSEA1+ cells also expressed Prx (28/28 examined cells)
(Figure 3F). This result suggested that Prx and probably other
intermediate-specific genes are expressed homogeneously
among SSEA1+ cells and thus mark cells poised to becoming
iPSCs. In contrast, other intermediate-specific genes such as
Tbx21 are expressed in more rare subsets of SSEA1+ cells (Fig-
ure 3D) whose fate remains unclear. To test whether activation of
the latter group of genes correlated with their ability to form
iPSCs, we infected tail fibroblasts isolated from Tbx21-ZsGreen
mice with a polycistronic viral vector expressing OKSM. Flow
cytometric analysis of SSEA1+ intermediates at days 6 and 9
confirmed the heterogeneous expression pattern (Figure 3G).
Plating of equal numbers of SSEA1+ Tbx21-ZsGreen+ and of
SSEA1+ Tbx21-ZsGreen- cells from day 6 on feeders gave
rise to roughly equal numbers of iPSC colonies, indicating
that Tbx21 upregulation at this time point was neither necessary
nor inhibitory for reprogramming (Figure 3H). However, SSEA1+(B) COA of same groups as shown in (A) illustrates variation in gene expression.
(C) Biplot displaying overlay of COA with genes associated with individual group
(D) Comparison of Affymetrix (left) and single-cell (right) expression data for nine se
candidates are shown in brackets.
(E) Immunofluorescence for Oct4, SSEA1, and Prx on reprogrammable MEFs tre
(F) Quantification of data shown in (E).
(G) FACS analysis of Tbx21-ZsGreen tail fibroblasts infected with dox-inducible
(H) Reprogramming potentials of indicated cell populations at days 6 and 9.
Data are represented as mean ± SEM (n = 3). See also Figure S2.
CTbx21-ZsGreen+ cells isolated at day 9 of reprogramming
almost entirely lost their ability to form iPSC colonies, suggesting
that a failure to downregulate this marker at later stages of re-
programming prohibited iPSC formation (Figures 3G and 3H).
We conclude that our analysis of SSEA1+ bulk populations
correlates well with expression patterns in individual SSEA1+
cells, thus validating our approach to study FACS-enriched inter-
mediates of reprogramming. However, our observation that
SSEA1+ cells exhibited some degree of heterogeneity warrants
a search for markers that allow for further purification of reprog-
ramming intermediates destined to form iPSCs (see Identifica-
tion of Molecules to Enrich for Cells Poised to Becoming iPSCs).
Comparison with piPSCs and Bulk Populations
Expressing OKSM
Partially reprogrammed iPSCs (piPSCs) are assumed to repre-
sent intermediate stages of reprogramming (Mikkelsen et al.,
2008; Sridharan et al., 2009). piPSC lines are stable cell lines
that have silenced the somatic program but failed to activate
the pluripotency program and depend on continuous expression
of viral transgenes. To assess whether their overall gene expres-
sion signature closely resembled any of our profiled cell popula-
tions, we performed PCA analysis between our data sets and
published results from six different piPSC lines. Consistent
with previous observations, piPSC lines derived from distinct
cell types and produced in different laboratories clustered
together, suggesting a similar molecular makeup (Figure S1D,
gray symbols). Unexpectedly, these cell lines were quite distinct
from any of our profiled intermediate populations along the
depicted PC axes, showing essentially no overlap with one
notable exception; piPSC line BIV1 (Mikkelsen et al., 2008) that
was generatedwith dox-inducible lentiviruses clustered together
with retrovirally induced piPSCs in the presence of dox (‘‘dox+’’
marked triangle) but grouped with our late SSEA1+ intermedi-
ates after 10 days of dox withdrawal (‘‘dox-’’ triangle). We
conclude that piPSCs originate from cells that have exited the
normal reprogramming route at an early time point and became
immortalized, hence showing little overlap with progressing
intermediates.
A comparison of gene expression profiles from SSEA1+ inter-
mediates with those obtained from reprogrammable ‘‘sec-
ondary’’ cells exposed as bulk populations to dox for 0, 4, 8,
12, or 16 days (Mikkelsen et al., 2008) further showed that the
latter samples clustered most closely with Thy1+ and Thy1
cells around day 3 but not with SSEA1+ intermediates at compa-
rable later time points (Figure S1D, turquois triangles). This
finding indicated that this previous study of bulk populations
predominantly captured expression changes of cells that failed
to reprogram after day 3 and underscores the importance ofSize of ovals indicates degree of variation.
s.
lected genes. Gene expression categories, as defined in Figure 2E, of selected
ated with dox for 9 days.
lentivirus expressing OKSM at indicated time points.
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Figure 4. Predicted Reprogramming Factor Activities and MicroRNA Expression Dynamics
(A) Transcription factor (TF) activities for c-Myc, Klf4 and the Sox2-Oct4 dimer based on network component analysis. Shown below are examples of activated
(red) or repressed (green) targets.
(B) Expression dynamics of an early (Fut9; left) and late (Lefty1; right) Oct4/Sox2 target during reprogramming. Shown below is promoter ChIP analysis for Oct4
and Sox2.
(C) Principle component analysis of microRNA expression data of FACS-sorted subpopulations at the indicated time points.
(D) Unsupervised hierarchical clustering of indicated microRNA expression profiles.
(E) Number of differentially expressed (DE) microRNAs between Thy1+ and SSEA1+ cells at indicated time points.
(legend continued on next page)
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enriching for the rare subsets of cells that are prone to generating
iPSCs, particularly at later stages of reprogramming.
Transcription Dynamics Predicts Distinct
Reprogramming Factor Activities
We next wondered whether the biphasic transcriptional pattern
could be explained by the activity of any individual or combina-
tions of transcription factors. To this end, we compared our
gene expression data with published genome-wide occupancy
studies for Oct4, Sox2, Klf4, c-Myc, and Nanog in pluripotent
stem cells (see Table S1 and Extended Experimental Proce-
dures). Whereas a similar number of targets of Oct4, Sox2, and
Klf4 were up- and downregulated during both transcriptional
waves, targets of c-Myc were mostly upregulated (80%) with
a bias for the first wave (Figure S3A).
Given that many pluripotency-associated genes are targets of
Oct4, Sox2, Klf4, and c-Myc in ESCs/iPSCs, we next distin-
guished between expression changes of individual and com-
binatorial OKSM targets during both waves. This analysis
confirmed that c-Myc alone or in combination with other factors
is a dominant force behind early gene induction (shown for c-
Myc and Klf4 targets in Figure S3B). To assess the contributions
from individual factors to reprogramming, we applied a mathe-
matical approach that models and predicts transcription factor
activities by using network component analysis (Chang et al.,
2008). As expected, c-Myc targets showed a striking upre-
gulation during the first few days of OKSM expression, with no
major changes detectable until the end of reprogramming (Fig-
ure 4A, left).
Notably, an analysis of transcriptional activity for genes that
are bound by pairs of factors in ESCs showed a gradual change,
as exemplified for Oct4/Sox2 (OS) targets, suggesting that the
combined activity of certain pluripotency factors is more likely
to modulate targets than individual factors (Figure 4A, middle).
To experimentally verify this mathematical prediction, we picked
3 OS targets that became upregulated early (Fut9, day 3) or late
(Nanog and Lefty1, days 9–12) during reprogramming and per-
formed chromatin immunoprecipitation (ChIP) on SSEA1+ inter-
mediates with Oct4- and Sox2-specific antibodies, combined
with real time PCR. Indeed, we found that Fut9 was occupied
by both Oct4 and Sox2 as early as day 3, whereas Nanog and
Lefty1 were occupied by Oct4 alone at early time points and
by both Oct4 and Sox2 by day 12, consistent with their robust
transcriptional activation (Figure 4B and Figure S3C). The
different susceptibilities of OS targets to be transcriptionally acti-
vated correlated well with an underlying permissive or repressive
chromatin structure (Figure S3D).
Klf4 was exceptional in that its targets changed their expres-
sion early and late in reprogramming with a phase of less
activity change during intermediate stages (days 3 to 9), sup-
porting a possible dual role of Klf4 in early somatic gene repres-(F) Number of differentially expressed microRNAs between progressing SSEA1+
(G) Examples of microRNA profiles that change in dynamic patterns.
(H) Predicted target genes of let-7c (Targetscan database) are shown based on
inverse expression score of 0.8 or lower are shown. Targets marked by red as
(I and J) iPSC formation efficiencies (I) and Oct4-GFP FACS quantification of rep
Data are represented as mean ± SEM (n = 3). See also Figure S3.
Csion and subsequent pluripotency gene activation (Figure 4A,
right). Accordingly, regulated Klf4 targets were comprised of
factors associated with differentiation, such as Tgfb1, Pdgfra,
and Col6a1, at early time points and of pluripotency-associated
genes including Pou5f1 (Oct4), Tdgf1, and Klf5 at late time
points of reprogramming. Altogether, these results suggest
that the first transcriptional wave is mostly mediated by c-Myc
and occurs in both progressing and nonprogressing cells,
whereas the second wave is the consequence of a gradual
upregulation of OS targets, ultimately leading to the activation
of other pluripotency genes, including Nanog, to consolidate
the pluripotent transcription factor network. Klf4 seems to
support both phases by suppressing genes during the first
phase and enhancing pluripotency gene expression during the
second phase.
MicroRNA Expression Follows Biphasic Pattern and
Inversely Correlates with Known and Predicted Target
mRNAs
Similar to the expression analysis for coding genes, miRNA
expression analysis allowed us to cluster cell populations into
different groups based on their phenotype by using PCA and
unsupervised clustering (Figures 4C–4E and Table S2). Pairwise
comparisons of progressing SSEA1+ populations at successive
time points again revealed two transcriptional waves, which both
showed an over representation of downregulated versus upre-
gulated miRNAs (Figure 4F). miRNAs changed their expression
in similar patterns to mRNAs over the course of reprogramming
(see Figure 4G for representative examples). Moreover, miRNAs
that have previously been documented to inhibit (e.g., let-7, miR-
34c) or promote (e.g., miR-294, miR-106a) (Huo and Zambidis,
2012) iPSC formation, showed the expected downregulation
and upregulation, respectively, in progressing intermediates
(Figure 4G and Figure S3E). We conclude that forced expression
of OKSM controls the expression of both coding and noncoding
loci in a similar fashion.
A comparison of many miRNAs and their known targets indi-
cated an inverse correlation (Figure S3E). This is exemplified
for miR-294, which targets TgfbR2, and for let-7, which targets
Lin28 (Subramanyam and Blelloch, 2011). To extend this anal-
ysis beyond well-established miRNA-mRNA pairs, we built
a table that links the expression changes during reprogramming
of all differentially expressed miRNAs to their putative mRNA
targets (Figure 4H, Figure S3F and Extended Experimental
Procedures). Indeed, the previously validated let-7c targets
Lin28, N-Myc, and Sall4 and the miR-294 targets Lats2, TgfbR2,
and Akt1 exhibited high negative correlation scores (Figure S3F).
This analysis further suggested that the pluripotency factor
Esrrb, the histone methyltransferases Suv39h1/2, and the coac-
tivator Ncoa3, all of which are implicated in cellular reprogram-
ming, are likely targets of let-7c, whereas the documentedcell populations at successive time points.
inverse expression patterns with let-7c. Examples of putative targets with an
terisks have previously been validated.
rogrammable MEFs treated with mimics for miR-182 or miR-214 (J).
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Figure 5. Histone and DNA Methylation Dynamics during Cellular Reprogramming
(A and B) Enrichment for H3K4me3 or H3K27me3 at promoters of differentially expressed genes in progressing intermediates.
(C and D) Superimposition of principal component analyses for genes enriched in H3K4me3 (C) or H3K27me3 (D) (triangles) with gene expression data (circles) of
the same cell populations (see Figure 2A for color coding).
(E) Display of activated genes from gene expression categories I, II, and III (see Figure 2E) in relation to their chromatin status in MEFs.
(F) Number of differentially expressed genes that become bivalent (H3K27me3 and H3K4me3 enriched) during reprogramming (red dots = bivalent promoters)
and quantification.
(legend continued on next page)
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iPSC-inhibitory factor Prrx1 (Yang et al., 2011) is predicted to be
targeted by miR-294.
Unexpectedly, miR-302a, whose forced expression was also
shown to enhance iPSC generation in the context of the Yama-
naka factors (Subramanyam and Blelloch, 2011), exhibited
transient activation specifically in Oct4-GFP+ cells at day 12
but remained otherwise unchanged (Figures S3G and S3H).
Mir-302a is normally expressed in mouse epiblast stem cells
(Huo and Zambidis, 2012) but barely detectable in mouse
ESCs, suggesting that iPSC induction might entail a transient
passage through an epiblast-like state before reaching naive
pluripotency. In agreement with this idea, we detected transient
downregulation of a number of putativemir-302a targets in Oct4-
GFP+ cells such asRbl2, Rab11fip5, Rbbp6, and transient, albeit
modest, upregulation of epiblast stem cell-associated markers
including Brachyury (T), Cer1, Foxa2, Eomes, and Fgf5 (Figures
S3G and S3I). It remains to be tested whether activation of
miR-302a and associated transcripts takes place in all or only
a subset of Oct4-expressing intermediate cells. Also, we cannot
rule out the possibility that these transient expression changes
are the result of aberrant targeting of exogenous OKSM to the
respective genes, resulting in their activation or repression.
We finally wondered whether our miRNA expression data
would allow us to identify novel modulators of reprogramming.
Indeed, gain-of-function of miR-182 by mimics increased,
whereas that of miR-214 decreased iPSC formation, consistent
with their transcriptional changes during reprogramming (Fig-
ures 4G, 4I, and 4J).
Differential Chromatin States Provide an Epigenetic
Logic for Early, Gradual, and Late Gene Regulation
We and others have previously shown that both transcriptional
and DNA/histone methylation patterns are reset from a somatic
state to a pluripotent state upon reprogramming into iPSCs
(Maherali et al., 2007; Mikkelsen et al., 2008). However, it is
unknown when these epigenetic changes occur during reprog-
ramming and whether there is a hierarchy in their establishment
and erasure, respectively. In an attempt to resolve these ques-
tions, we analyzed active and repressive histone methylation
marks (histone H3 lysine 4 and lysine 27 trimethylation
H3K4me3/H3K27me3) and DNA methylation patterns at a
genome-wide scale in SSEA1+ cells throughout reprogramming.
Analysis of H3K4me3 and H3K27me3 ChIP-seq patterns in pro-
gressing intermediates showed two waves (Figures 5A and 5B),
which coincided with the observed mRNA and miRNA phases
(Figures 5C and 5D). Kinetic analysis of bivalency formation
(H3K4me3/H3K27me3 enriched promoters) (Bernstein et al.,
2006) at genes that changed expression during reprogramming
showed an initial burst of110 targets by day 3, which gradually
increased to130 at day 9,160 by day 12, and180 in estab-(G) Integration of gene expression and histone modification data define subse
fibroblast-associated (top), pluripotency-associated (center), and transiently cha
(H) Number of genes, which change DNA methylation status in progressing cell p
analysis (HELP).
(I) Expression dynamics of candidate genes associated with DNA methylation an
(J) Heatmap of DNA methylation patterns of specific CpGs (boxes) in the prom
methylation analyses. Yellow indicates 0% methylation, and blue represents 100
See also Figure S4.
Clished iPSCs (Figure 5F, Figure S4A). Thus, activating and
repressive histone marks individually exhibit a biphasic pattern
akin to coding and noncoding genes, whereas the establishment
of differentially expressed bivalent promoters is a more gradual
process.
An examination of histone marks at genes that changed their
transcription in characteristic patterns allowed us to study their
underlying chromatin dynamics (Figure 5G and Table S1).
Consistent with the different gene expression categories (Fig-
ure 2E), wewere able to distinguish between genes that changed
their H3K4me3 and H3K27me3 status early (day 3), at interme-
diate stages (day 6–9), or late (day 12). For example, the fibro-
blast-associated gene Pdgfrb was downregulated by day 3,
which coincided with the early loss of H3K4me3 and subsequent
acquisition of H3K27me3 marks, suggesting efficient access of
this locus by chromatin silencers. In contrast, the MEF-
expressed gene Zfpm2 showed a gradual decrease in
H3K4me3 marks and a concomitant increase in H3K27me3
marks, resulting in a bivalent state and transcriptional silencing
around day 9, whereas the Lats2 gene became decorated by
H3K27me3 and was transcriptionally silenced only by day 12.
Similar to the deposition of H3K27me3 marks and the
concomitant silencing of MEF-specific genes, we observed
distinct classes of pluripotency genes that gained H3K4me3
and lost H3K27me3 at different time points (e.g., Fgf4, Sall4,
and Lin28) (Figure 5G). Lastly, genes that changed their expres-
sion transiently acquired H3K4me3 or H3K27me3 in a temporally
restricted manner (e.g., Prx, Klf2) (Figure 5G). We deduce from
these results that the kinetics of silencing of MEF genes and
activation of ESC genes is determined by a combination of
parameters, including the type and complexity of underlying
histone modifications as well as the availability and accessibility
of transcription factors to regulate a given target (see Figure 4B).
Indeed, the vast majority of genes (90%) that were activated
early or gradually (categories I and II; see Figure 2E) already
carried activating H3K4me3 marks in MEFs (Figure 5E and Fig-
ure S4B), thus complementing observations made in a previous
study (Koche et al., 2011). In contrast, genes that were activated
late (category III, e.g., Oct4, Nanog) are often unmarked (15%
of genes) or bivalent (15%) in MEFs, suggesting that loci asso-
ciated with these chromatin patterns are more resistant to tran-
scriptional activation.
DNA Methylation Patterns Are Reset Late in
Reprogramming
In contrast to gene expression and histone modification
patterns, genome-wide promoter DNA methylation changes
occurred predominantly late in reprogramming as determined
by HELP analysis (Figure 5H). Equal numbers of methylated
restriction sites were gained and lost after day 9, indicatingts of genes with characteristic expression changes. Shown are examples of
nging genes (bottom).
opulations during reprogramming as determined by genome-wide methylation
d demethylation.
oter regions of indicated genes during reprogramming with EpiTYPER DNA
% methylation.
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Figure 6. Rescue of Refractory Thy1+ Cells by Increased OKSM Expression
(A) Box plot depicting average expression levels in Thy1+ cells, Thy1 cells and SSEA1+ cells of genes that are significantly upregulated between MEFs
and iPSCs.
(B) Expression dynamics of indicated MEF-associated and ESC-associated transcripts in Thy1+, Thy1 and SSEA1+ cells (see Figure 2A for color coding).
(C) Exogenous Oct4 expression levels, normalized to GAPDH for the indicated cell populations and time points.
(D) Western blot analysis for Oct4 and gamma-tubulin (g-tub) for the indicated cell populations and time points. Higher molecular weight band for exogenous
Oct4 compared with endogenous Oct4 (iPSC) reflects unprocessed protein originating from the polycistronic construct as described previously by Carey et al.
(2011).
(E) Densitometric quantification of western blot analysis shown in (D). AU is an abbreviation for arbitrary units.
(F) FACS analysis of reprogrammable fibroblasts carrying one (Het/Het) or two (Ho/Ho) copies each of the OKSM cassette and Rosa26-M2rtTA allele (top row).
Bottom row shows FACS analysis for SSEA1 and Oct4-GFP of the same samples.
(G) Experimental outline to rescue refractory Thy1+ cells by supplying viral copies of OKSM.
(legend continued on next page)
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that a comparable number of loci became methylated and de-
methylated, respectively. In agreement, we found that enzymes
implicated in DNA methylation and demethylation, such as
Dnmt3a, Dnmt3L, Apobec2, and Tet1 were transcriptionally up-
regulated late and specifically in SSEA1+ cells (Figure 5I). To
confirm these global changes of DNA methylation at single
base-resolution, we investigated promoter methylation levels
at a number of candidate loci by mass array EpiTYPEr on
genomic DNA isolated from SSEA1+ intermediates. We found
that pluripotency-associated genes, such as Nanog, Oct4, and
Zfp42 (Rex1) became demethylated very late during reprogram-
ming (days 9–12) (Figure 5J and Table S3). Similarly, genes that
are normally methylated in pluripotent cells but demethylated in
fibroblasts, including HoxA10 and Gja8, became de novo meth-
ylated late.
Rescue of Refractory Cells by Increased OKSM
Expression
A comparison of gene expression intensities among the different
subpopulations showed that Thy1 and Thy1+ cells generally
failed to regulate ESC-enriched and MEF-enriched mRNAs and
miRNAs to the same extent as SSEA1+ cells (Figures 6A and
6B). Although this observation cannot be explained by differen-
tial transcription of the OKSM transgene in these subpopulations
(Figure 6C), we were surprised to detect substantially increased
protein levels for Oct4 in SSEA1+ cells compared with Thy1+
cells (Figures 6D and 6E). Consistently, we observed a 20%–
25% reduction in the number of Thy1+ and Thy1 cells and
a concomitant 400% increase in the number of SSEA1+ cells
when inducing reprogrammable MEFs carrying two copies of
the OKSM cassette and Rosa26-M2rtTA allele (Ho/Ho), respec-
tively, with dox compared with MEFs that only contained one
copy of each transgene (Het/Het) (Figure 6F).
To test whether elevated OKSM protein levels could rescue
refractory Thy1+ cells at different stages of reprogramming, we
infected Thy1+ cells isolated at days 3, 6, 9, and 12 of dox induc-
tion from Het/Het reprogrammable MEFs with viral vectors ex-
pressing additional copies of OKSM (Figure 6G). Remarkably,
Thy1+ cells receiving extra copies of OKSM, but not untreated
control cells or cells infected with c-Myc vector alone, gave
rise to a substantial number of Oct4-GFP+ iPSC colonies
(Figures 6H and 6I). This result thus documents that the inability
to sustain OKSM protein expression in Thy1+ cells on or after
day 3 contributes to their failure to form iPSCs.
Identification of Molecules to Enrich for Cells Poised to
Becoming iPSCs
In a last set of experiments, we aimed to identify new surface
markers that would allow further enrichment for subpopulations
of cells undergoing reprogramming in comparison with Thy1,
SSEA1, and Oct4-GFP expression. We focused on the mole-
cules c-Kit, EpCAM, and PECAM1 because of their expression
patterns specifically in SSEA1+ intermediates (EpCAM, early(H) Alkaline phosphatase stained colonies obtained after infecting Thy1+ reprogra
Controls were uninfected, dox-treated Thy1+ cells (‘‘Dox’’) and Thy1+ cells infecte
bottom.
(I) Quantification of results in (G). Data are represented as mean ± S.E.M. (n = 3)
Cgene; c-Kit, intermediate gene; PECAM1, late gene) (Figure 7A
and Figure S5A). Notably, EpCAM+ cells were first detectable
at day 6 in a fraction (25%) of SSEA1+ cells. In contrast,
c-Kit became upregulated only by day 9 in 25% of SSEA1+
cells, whereas PECAM1 was detectable exclusively in
SSEA1+, Oct4-GFP+ cells at day 9. Altogether, these results
show that EpCAM, c-Kit, and PECAM1 become activated at
successive time points in subsets of SSEA1+ cells. This experi-
ment further documents that SSEA1+ intermediates that acti-
vated the endogenous Oct4(-GFP) locus are generally more
homogeneous for these three markers than are SSEA1+ Oct4-
GFP- cells at day 6 and day 9.
To assess the functional value of these markers, we sorted
SSEA1+ EpCAM and SSEA1+ EpCAM+ cells 6 days after
dox induction and plated equal numbers on feeders for another
8 days in the presence of dox. Counting of dox-independent
alkaline phosphatase-positive colonies 5 days later showed
a modest but significant increase in reprogramming efficiency
among SSEA1+ EpCAM+ intermediates (Figure 7B). In agree-
ment, expression analysis of both subpopulations revealed
subtle differences with 68 genes being upregulated and 48
genes being downregulated more than 2-fold (Figure 7C). Upre-
gulated genes included Nanog (11-fold), ERas (7-fold), Sox2,
Nr0b1, Sall4, Nr5a2, and Tdgf1 (3- to 5-fold). Surprisingly, the
core transcription factor Oct4 was not differentially expressed,
which is consistent with the absence of Oct4-GFP signal at
this time point. At the epigenetic level, Nanog promoter methyl-
ation levels were reduced by 50%, whereas Oct4 promoter
methylation levels decreased only mildly (Figure 7D and Fig-
ure S5B). These findings thus suggest that there is a hierarchy
in the activation of core pluripotency factors within SSEA1+ cells
with Nanog and associated transcripts being activated before
Oct4.
DISCUSSION
Our results constitute a comprehensive analysis of transcrip-
tional and epigenetic changes in phenotypically defined in-
termediates of iPSC induction. These data have elucidated the
identity and order of molecular changes inherent to transcription
factor-induced reprogramming (see Figure 7 for summary of
observations) and provide a rich resource of data to further
dissect themechanisms of induced cell fate transitions. Our find-
ings suggest that the reprogramming of somatic cells follows
a similar sequence of epigenetic changes as is seen during
normal somatic cell differentiation; differentiating cells are
thought to undergo transcriptional and histone modification
changes before DNA methylation changes (Jones, 2012). It will
be interesting to assess whether the rather abrupt loss of
methylation after day 9 is solely the consequence of a replica-
tion-dependent passive process or also involves active deme-
thylation. Notably, methylation changes coincided with the
acquisition of a stably reprogrammed state and are in line withmmable cells at indicated days with a dox-inducible vector expressing OKSM.
d with c-Myc virus alone. Representative Oct4-GFP+ colonies are shown at the
.
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Figure 7. Identification of Surface Markers to Enrich for Reprogramming Intermediates, and Model
(A) Expression data and histogram plots of FACS analysis for c-Kit, EpCAM, and PECAM1 in SSEA1+ and Oct4-GFP+ populations at the indicated days of
reprogramming. Red lines depict antibody-specific signal, blue lines show signal obtained with isotype control. No expression was seen before day 6.
(B) Potential of EpCAM subpopulations at day 6 to form iPSC colonies.
(C) Affymetrix expression analysis of EpCAM subpopulations.
(D) Methylation analysis of Nanog promoter by bisulfite sequencing of ESCs, MEFs and intermediates shown in (B). The following abbreviations are
used: S, SSEA1; Ep, EpCAM.
(legend continued on next page)
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the interpretation that methylation patterns stably lock in the re-
programmed state.
Our molecular analysis allowed us to define nine categories
of dynamically expressed genes, which characterize distinct
stages of reprogramming and whose overexpression or knock-
down enhanced iPSC formation. We surmise that a failure to
activate these (Figure 2F) and related genes constitute road-
blocks of reprogramming and is part of the reason why iPSC
formation is inefficient and takes relatively long. Our observation
of two major transcriptional waves and an intermediate period of
less transcriptional change is reminiscent of a previous study
that has identified an ‘‘initiation,’’ ‘‘maturation,’’ and ‘‘stabiliza-
tion’’ phasewhen examining bulk populations of cells expressing
OKSM (Samavarchi-Tehrani et al., 2010). The observed transient
activation/repression of developmental regulators may indicate
that the OKSMproteins aberrantly activate/repress these targets
or, alternatively, that (some) reprogramming intermediates
undergo a transient phase of transdifferentiation or dedifferenti-
ation as part of the reprogramming process. Our results might
thus explain recent successes in deriving epiblast stem cells,
neural progenitors, or cardiomyocytes directly from fibroblasts
upon brief expression of OKSM and exposure to culture con-
ditions conducive of the respective cell type (Orkin and Hoched-
linger, 2011). This finding could be potentially exploited to
generate other desired cell fates directly from fibroblasts.
We have applied a mathematical model that faithfully predicts
activation of OKSM targets in the course of reprogramming. Our
results provide a transcriptional logic for the previously seen
early requirement for c-Myc (Sridharan et al., 2009) and the
late requirement for Sox2 (Chen et al., 2011) during reprogram-
ming and suggest an unanticipated dual function for Klf4 by
predominantly repressing somatic targets early and activating
pluripotency targets late in iPSC formation. Our finding that
Thy1+ refractory cells produce less OKSM protein and thus fail
to properly regulate target gene expression compared with
SSEA1+ cells warrants further examination. One plausible
molecular explanation is that the OKSM factors are prone to
more ubiquitination-mediated degradation in Thy1+ cells (Buck-
ley et al., 2012).
We recognize the fact that SSEA1+ cells, although enriched
for cells poised to forming iPSCs, still exhibit some degree of
heterogeneity. Single-cell analysis of 26 genes as well as
FACS analysis of three additional genes (EpCAM, c-Kit, and
PECAM) documented that gene expression changes occur
more homogeneously at early (0–3 days) and late time points
(day 9 onward), whereas they are more heterogeneous at
intermediate stages (days 6–9). There is some debate as to
whether reprogramming entails a hierarchic/deterministic or
probabilistic/stochastic process (Yamanaka, 2009). A previous
study identified an early deterministic phase of reprogramming
(Smith et al., 2010), whereas another recent report concluded
that reprogramming involves an early stochastic and a late(E) Model summarizing the presented data. Permissive cell populations (positive y
marks. Bivalent domains are generated gradually after an initial burst. DNA me
expression of OKSM in refractory cells (negative y axis) can rescue their ability to
drive the second phase.
See also Figure S5.
Cdeterministic phase (Buganim et al., 2012). Our data may
explain both observations, and we therefore suggest that
iPSC formation follows an early and late deterministic phase,
which is separated by a more probabilistic phase. With the
aid of new surface marker, such as EpCAM, PECAM, and
c-Kit, or novel reporter alleles, it may be possible to identify
rare intermediates that progress toward iPSCs in a purely
deterministic manner.
EXPERIMENTAL PROCEDURES
Reprogramming Experiments
iPSCs were derived from MEFs or tail tip fibroblasts of reprogrammable mice
(Stadtfeld et al., 2010) or directly infected with polycistronic lentivirus ex-
pressing Oct4, Sox2, Klf4, and c-Myc as described in detail in Extended
Experimental Procedures.
Flow Cytometry and Immunofluorescence
Flow cytometry for GFP, Thy1, SSEA1, EpCAM, PECAM, and c-Kit was done
as reported previously (Stadtfeld et al., 2008) and/or as described in Extended
Experimental Procedures.
RNA Analysis
Gene expression profiling was performed with Affymetrix arrays. MicroRNA
profiling was obtained with the Exiqon platform. Details are given in Extended
Experimental Procedures.
Single-Cell Expression Analysis
Single-cell expression analysis was performed with Fluidigm technology
for 26 genes with Taqman probes as described in Extended Experimental
Procedures and Table S1.
HELP and MassARRAY EpiTyping DNA Methylation Analysis
These analyses were performed as described before (Polo et al., 2010). Details
are given in the Extended Experimental Procedures and Table S1.
Chromatin Immunoprecipitation
ChIP analysis was essentially as described previously (Polo et al., 2010).
Please see Extended Experimental Procedures and Table S1 for details.
ChIP-Seq Analysis
ChIP products from H3K4Me3 and H3K27Me3 pulldowns were subjected to
high throughput sequencingwith the GA/IIX Illumina platform. Details are given
in the Extended Experimental Procedures.
Statistical and Bioinformatic Analyses
See Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, and three tables and can be found with this article online at http://
dx.doi.org/10.1016/j.cell.2012.11.039.
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